spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  lipoatrophy 

 HSMN NewsFeed - 13 Feb 2018
Sandoz announces US FDA approval and launch of Glatopa(R) 40 mg/mL three times-a-week generic option for relapsing forms of multiple sclerosis
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 24 Sep 2015
Pfizer’s Sayana(R) Press Becomes First Injectable Contraceptive In The United Kingdom Available For Administration By Self-Injection
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 15 Jul 2015
OncoCyte Announces Appointment of Andy Arno to Board of Directors
Diagnostics Oncology Personnel
 HSMN NewsFeed - 16 Jun 2015
William Annett Named Chief Executive Officer of OncoCyte Corporation
Diagnostics Oncology Personnel
 HSMN NewsFeed - 14 May 2015
OncoCyte Corporation Completes Equity Financing Round
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 29 Dec 2014
BioTime Appoints Adi Mohanty Chief Operating Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 28 Jan 2014
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE(R) (glatiramer acetate injection) 40mg/mL
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 15 Apr 2010
Contura Submits Registration Application for Aquamid(R) to the FDA
Devices Dermatology FDA
 HSMN NewsFeed - 2 Feb 2010
Two Studies Find Artefill(R) to Be a Long-Term Treatment Option for Facial Lipoatrophy
Devices Dermatology
 HSMN NewsFeed - 29 Oct 2007
Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV Patients
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 21 Sep 2007
Norditropin(R) Approved for Treatment of Children with Short Stature Associated with Turner Syndrome
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Jun 2007
FDA Approves Norditropin(R)for Treatment of Short Stature Associated with a Rare Genetic Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Dec 2006
FDA Approves Radiesse(R) Facial Filler for Two New Aesthetic Indications
Devices Dermatology FDA
 HSMN NewsFeed - 30 Oct 2006
CryoLife Announces Agreement With BioForm Medical to Develop and Market BioGlue(R) for Use In Cosmetic and Plastic Surgery
Devices Licensing Distribution
 HSMN NewsFeed - 30 Oct 2006
New Study Shows Sculptra(R) (injectable poly-L-lactic acid), a Unique Class of Injectable for Cosmetic Use, Provides 13 Month Results
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 19 Sep 2006
Dermik Laboratories Announces FDA Acceptance of Supplemental Filing Application for Sculptra(R)
Biopharmaceuticals Dermatology FDA
Return to NewsFeed  

 Additional items found! 12

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 12 additional stories matching:
lipoatrophy
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.